HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
101	14523 Cairns NJ, Lee VMY, Trojanowski JQ The cytoskeleton in neurodegenerative diseases JOURNAL OF PATHOLOGY. 2004 NOV; 204 (4): 438-449	52	52	99	125
102	26945 Archer T, Kostrzewa RM, Beninger RJ, Palomo T Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions NEUROTOXICITY RESEARCH. 2011 FEB; 19 (2): 211-234	0	0	99	339
103	16496 Gong CX, Liu F, Grundke-Iqbal I, Iqbal K Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: A therapeutic target JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 31825	0	16	98	159
104	13682 Sidhu A, Wersinger C, Vernier P Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB JOURNAL. 2004 APR; 18 (6): 637-647	46	65	97	145
105	14383 von Bohlen und Halbach O Synucleins and their relationship to Parkinson's disease CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 163-174	11	15	97	143
106	19784 Ahmad M, Attoub S, Singh MN, Martin FL, El-Agnaf OMA gamma-synuclein and the progression of cancer FASEB JOURNAL. 2007 NOV; 21 (13): 3419-3430	7	11	97	144
107	23099 Olanow CW, Stern MB, Sethi K The scientific and clinical basis for the treatment of Parkinson disease (2009) NEUROLOGY. 2009 MAY 26; 72 (21): S1-S136	5	44	97	1050
108	26336 Yasuda T, Mochizuki H The regulatory role of alpha-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease APOPTOSIS. 2010 NOV; 15 (11): 1312-1321	2	3	97	159
109	10900 Avila J, Lim F, Moreno F, Belmonte C, Cuello AC Tau function and dysfunction in neurons - Its role in neurodegenerative disorders MOLECULAR NEUROBIOLOGY. 2002 JUN; 25 (3): 213-231	19	27	96	185
110	22662 George JL, Mok S, Moses D, Wilkins S, Bush AI, et al. Targeting the Progression of Parkinson's Disease CURRENT NEUROPHARMACOLOGY. 2009 MAR; 7 (1): 9-36	2	5	96	454
#	Date / Author / Journal	LCS	GCS	LCR	CR
111	23522 Craig-Schapiro R, Fagan AM, Holtzman DM Biomarkers of Alzheimer's disease NEUROBIOLOGY OF DISEASE. 2009 AUG; 35 (2): 128-140	11	17	96	298
112	17947 Olanow CW, McNaught KS Ubiquitin-proteasome system and Parkinson's disease MOVEMENT DISORDERS. 2006 NOV; 21 (11): 1806-1823	16	45	95	231
113	16999 McNaught KSP, Olanow CW Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease NEUROBIOLOGY OF AGING. 2006 APR; 27 (4): 530-545	25	57	94	256
114	20318 Halliday GM, McCann H Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms EXPERIMENTAL NEUROLOGY. 2008 JAN; 209 (1): 12-21	8	10	94	139
115	22805 Levy OA, Malagelada C, Greene LA Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps APOPTOSIS. 2009 APR; 14 (4): 478-500	7	28	94	239
116	12317 Lee SJ alpha-synuclein aggregation: A link between mitochondrial defects and Parkinson's disease? ANTIOXIDANTS & REDOX SIGNALING. 2003 JUN; 5 (3): 337-348	14	20	93	138
117	17550 Beyer K alpha-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers ACTA NEUROPATHOLOGICA. 2006 SEP; 112 (3): 237-251	31	38	93	136
118	25453 Bento-Abreu A, Van Damme P, Van Den Bosch L, Robberecht W The neurobiology of amyotrophic lateral sclerosis EUROPEAN JOURNAL OF NEUROSCIENCE. 2010 JUN; 31 (12): 2247-2265	1	1	93	275
119	9704 Sanchez MP, Alvarez-Tallada V, Avila J The microtubule associated protein tau in neurodegenerative diseases. Tauopathies REVISTA DE NEUROLOGIA. 2001 JUL 16; 33 (2): 169-177	2	5	92	176
120	19888 Fiala JC Mechanisms of amyloid plaque pathogenesis ACTA NEUROPATHOLOGICA. 2007 DEC; 114 (6): 551-571	3	16	92	300
#	Date / Author / Journal	LCS	GCS	LCR	CR
121	22524 Bisaglia M, Mammi S, Bubacco L Structural insights on physiological functions and pathological effects of alpha-synuclein FASEB JOURNAL. 2009 FEB; 23 (2): 329-340	14	19	92	126
122	7684 Heininger K A unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 1999 DEC; 14 (8): 525-581	2	11	91	796
123	9078 Arendt T Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization NEUROSCIENCE. 2001; 102 (4): 723-765	14	85	91	836
124	14150 Huang Y, Cheung L, Rowe D, Halliday G Genetic contributions to Parkinson's disease BRAIN RESEARCH REVIEWS. 2004 AUG; 46 (1): 44-70	15	46	91	300
125	19700 Wakabayashi K, Tanji K, Mori F, Takahashi H The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of alpha-synuclein aggregates NEUROPATHOLOGY. 2007 OCT; 27 (5): 494-506	30	44	91	150
126	7217 Goedert M Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B- BIOLOGICAL SCIENCES. 1999 JUN 29; 354 (1386): 1101-1118	80	92	90	148
127	14915 Thompson HJ, Lifshitz J, Marklund N, Grady MS, Graham DI, et al. Lateral fluid percussion brain injury: A 15-year review and evaluation JOURNAL OF NEUROTRAUMA. 2005 JAN; 22 (1): 42-75	47	105	90	375
128	20334 Iqbal K, Grundke-Iqbal I Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2008 JAN-FEB; 12 (1): 38-55	13	27	90	166
129	23668 Bauer PO, Nukina N The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies JOURNAL OF NEUROCHEMISTRY. 2009 SEP; 110 (6): 1737-1765	6	19	90	360
130	25392 Bartolini M, Andrisano V Strategies for the Inhibition of Protein Aggregation in Human Diseases CHEMBIOCHEM. 2010 MAY 17; 11 (8): 1018-1035	1	6	90	302
#	Date / Author / Journal	LCS	GCS	LCR	CR
131	11642 Jellinger KA General aspects of neurodegeneration ADVANCES IN RESEARCH ON NEURODEGENERATION. 2003; 10: 101-144	0	0	89	198
132	11735 Jellinger KA General aspects of neurodegeneration JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2003; (65): 101-144	12	37	89	198
133	14968 Stoothoff WH, Johnson GVW Tau phosphorylation: physiological and pathological consequences BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 280-297	59	102	89	170
134	15782 Goedert M Tau gene mutations and their effects MOVEMENT DISORDERS. 2005 AUG; 20: S45-S52	18	31	89	97
135	20266 Duyckaerts C, Potier MC, Delatour B Alzheimer disease models and human neuropathology: similarities and differences ACTA NEUROPATHOLOGICA. 2008 JAN; 115 (1): 5-38	29	63	89	350
136	25546 Dawson TM, Ko HS, Dawson VL Genetic Animal Models of Parkinson's Disease NEURON. 2010 JUN 10; 66 (5): 646-661	3	5	89	161
137	26895 Uversky VN Flexible Nets of Malleable Guardians: Intrinsically Disordered Chaperones in Neurodegenerative Diseases CHEMICAL REVIEWS. 2011 FEB; 111 (2): 1134-1166	0	0	89	459
138	13196 Snyder H, Wolozin B Pathological proteins in Parkinson's disease JOURNAL OF MOLECULAR NEUROSCIENCE. 2004; 24 (3): 425-442	12	23	88	179
139	16591 Niewiadomska G, Baksalerska-Pazera M, Riedel G Cytoskeletal transport in the aging brain: Focus on the cholinergic system REVIEWS IN THE NEUROSCIENCES. 2006; 17 (6): 581-618	1	7	88	329
140	17139 Lashuel HA, Lansbury PT Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? QUARTERLY REVIEWS OF BIOPHYSICS. 2006 MAY; 39 (2): 167-201	23	101	88	307
#	Date / Author / Journal	LCS	GCS	LCR	CR
141	24968 Meraz-Rios MA, Lira-De Leon KI, Campos-Pena V, De Anda-Hernandez MA, Mena-Lopez R Tau oligomers and aggregation in Alzheimer's disease JOURNAL OF NEUROCHEMISTRY. 2010 MAR; 112 (6): 1353-1367	2	4	88	140
142	7472 Buee L, Delacourte A Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease BRAIN PATHOLOGY. 1999 OCT; 9 (4): 681-693	123	147	87	131
143	11765 Yancopoulou D, Spillantini MG Tau protein in familial and sporadic diseases NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 37-48	8	12	87	101
144	14953 D'Souza I, Schellenberg GD Regulation of tau isoform expression and dementia BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 104-115	36	43	87	117
145	22373 Biran Y, Masters CL, Barnham KJ, Bush AI, Adlard PA Pharmacotherapeutic targets in Alzheimer's disease JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2009 JAN; 13 (1): 61-86	4	11	87	427
146	23478 Madine J, Middleton DA TARGETING alpha-SYNUCLEIN AGGREGATION FOR PARKINSON'S DISEASE TREATMENT DRUGS OF THE FUTURE. 2009 AUG; 34 (8): 655-663	0	0	87	134
147	23858 Crews L, Tsigelny I, Hashimoto M, Masliah E Role of Synucleins in Alzheimer's Disease NEUROTOXICITY RESEARCH. 2009 OCT; 16 (3): 306-317	5	7	87	151
148	25800 Robinson PA Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy EXPERT REVIEW OF PROTEOMICS. 2010 AUG; 7 (4): 565-578	0	1	87	208
149	9568 Goedert M The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases CURRENT OPINION IN GENETICS & DEVELOPMENT. 2001 JUN; 11 (3): 343-351	44	48	86	95
150	11590 Ingram EM, Spillantini MG Tau gene mutations: dissecting the pathogenesis of FTDP-17 TRENDS IN MOLECULAR MEDICINE. 2002 DEC; 8 (12): 555-562	69	76	86	95
#	Date / Author / Journal	LCS	GCS	LCR	CR
151	15389 Norris EH, Giasson BI Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders ANTIOXIDANTS & REDOX SIGNALING. 2005 MAY-JUN; 7 (5-6): 673-684	2	3	86	136
152	22120 Gotz J, Gotz NN Animal models for Alzheimer's disease and frontotemporal dementia: a perspective ASN NEURO. 2009; 1 (4): Art. No. e00019	0	1	86	134
153	22676 Beyer K, Domingo-Sabat M, Ariza A Molecular Pathology of Lewy Body Diseases INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 724-745	6	7	86	145
154	23505 Geser F, Martinez-Lage M, Kwong LK, Lee VMY, Trojanowski JQ Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases JOURNAL OF NEUROLOGY. 2009 AUG; 256 (8): 1205-1214	30	30	86	108
155	24790 Grossman M Primary progressive aphasia: clinicopathological correlations NATURE REVIEWS NEUROLOGY. 2010 FEB; 6 (2): 88-97	7	9	86	129
156	21728 Ninkina NN, Ustyugov AA, Buchman VL Modeling Synucleinopathies in Genetically Modified Animals: Successes and Failures MOLECULAR BIOLOGY. 2008 OCT; 42 (5): 747-761	1	1	85	102
157	26572 Bekris LM, Mata IF, Zabetian CP The Genetics of Parkinson Disease JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2010 DEC; 23 (4): 228-242	0	0	85	215
158	13689 Bertoli-Avella AM, Oostra BA, Heutink P Chasing genes in Alzheimer's and Parkinson's disease HUMAN GENETICS. 2004 APR; 114 (5): 413-438	10	27	84	305
159	18225 Jellinger KA Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2007; (72): 91-104	6	11	84	168
160	23275 Lim KL, Ng CH Genetic models of Parkinson disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 604-615	3	8	84	156
#	Date / Author / Journal	LCS	GCS	LCR	CR
161	7902 Heininger K A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events REVIEWS IN THE NEUROSCIENCES. 2000; 11: 213-328	11	48	83	1849
162	14062 Gotz J, Streffer JR, David D, Schild A, Hoerndli F, et al. Transgenic animal models of Alzheimer's disease and related disorders: Histopathology, behavior and therapy MOLECULAR PSYCHIATRY. 2004 JUL; 9 (7): 664-683	58	101	83	206
163	20202 Dohm CP, Kermer P, Bahr M Aggregopathy in neurodegenerative diseases: Mechanisms and therapeutic implication NEURODEGENERATIVE DISEASES. 2008; 5 (6): 321-338	1	6	83	206
164	21429 Jellinger KA, Janetzky B, Attems J, Kienzl E Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene' - a new blood biomarker ? JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2008 AUG; 12 (4): 1094-1117	1	9	83	302
165	21723 van Swieten JC, Heutink P Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia LANCET NEUROLOGY. 2008 OCT; 7 (10): 965-974	15	21	83	104
166	23838 Brunden KR, Trojanowski JQ, Lee VMY Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies NATURE REVIEWS DRUG DISCOVERY. 2009 OCT; 8 (10): 783-793	25	25	83	137
167	6223 Anderton BH, Callahan L, Coleman P, Davies P, Flood D, et al. Dendritic changes in Alzheimer's disease and factors that may underlie these changes PROGRESS IN NEUROBIOLOGY. 1998 AUG; 55 (6): 595-609	16	47	82	191
168	15663 Kuret J, Congdon EE, Li GB, Yin HH, Yu X, et al. Evaluating triggers and enhancers of tau fibrillization MICROSCOPY RESEARCH AND TECHNIQUE. 2005 JUL; 67 (3-4): 141-155	19	25	82	160
169	15972 Kar A, Kuo D, He RQ, Zhou JW, Wu JY Tau alternative splicing and frontotemporal dementia ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19: S29-S36	6	8	82	90
170	19085 Inamdar NN, Arulmozhi DK, Tandon A, Bodhankar SL Parkinson's disease: Genetics and beyond CURRENT NEUROPHARMACOLOGY. 2007 JUN; 5 (2): 99-113	2	3	82	291
#	Date / Author / Journal	LCS	GCS	LCR	CR
171	20790 Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, et al. Biochemistry of Tau in Alzheimer's disease and related neurological disorders EXPERT REVIEW OF PROTEOMICS. 2008 APR; 5 (2): 207-224	15	18	82	161
172	25171 Chen-Plotkin AS, Lee VMY, Trojanowski JQ TAR DNA-binding protein 43 in neurodegenerative disease NATURE REVIEWS NEUROLOGY. 2010 APR; 6 (4): 211-220	11	11	82	121
173	26154 Wisniewski T, Sigurdsson EM Murine models of Alzheimer's disease and their use in developing immunotherapies BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 847-859	2	3	82	236
174	8383 Sanchez C, Diaz-Nido J, Avila J Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function PROGRESS IN NEUROBIOLOGY. 2000 JUN; 61 (2): 133-168	23	176	81	473
175	11094 Kahle PJ, Haass C, Kretzschmar HA, Neumann M Structure/function of alpha-synuclein in health and disease: rational development of animal models for Parkinson's and related diseases JOURNAL OF NEUROCHEMISTRY. 2002 AUG; 82 (3): 449-457	35	44	81	100
176	14960 Iqbal K, Alonso ADC, Chen S, Chohan MO, El-Akkad E, et al. Tau pathology in Alzheimer disease and other tauopathies BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 198-210	100	154	81	147
177	18166 Furumoto S, Okamura N, Iwata R, Yanai K, Arai H, et al. Recent advances in the development of amyloid Imaging agents CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2007; 7 (18): 1773-1789	5	15	81	167
178	20559 Wright JA, Brown DR Alpha-synuclein and its role in metal binding: Relevance to Parkinson's disease JOURNAL OF NEUROSCIENCE RESEARCH. 2008 FEB 15; 86 (3): 496-503	6	11	81	103
179	23440 Mollenhauer B, Trenkwalder C Neurochemical Biomarkers in the Differential Diagnosis of Movement Disorders MOVEMENT DISORDERS. 2009 JUL 30; 24 (10): 1411-1426	1	5	81	299
180	25177 Geser F, Lee VMY, Trojanowski JQ Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: A spectrum of TDP-43 proteinopathies NEUROPATHOLOGY. 2010 APR; 30 (2): 103-112	7	7	81	104
#	Date / Author / Journal	LCS	GCS	LCR	CR
181	25734 Schulz-Schaeffer WJ The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia ACTA NEUROPATHOLOGICA. 2010 AUG; 120 (2): 131-143	0	0	81	157
182	10323 Cole NB, Murphy DD The cell biology of alpha-synuclein - A sticky problem? NEUROMOLECULAR MEDICINE. 2002; 1 (2): 95-109	14	14	80	128
183	16751 Mukaetova-Ladinska EB, McKeith IG Pathophysiology of synuclein aggregation in Lewy body disease MECHANISMS OF AGEING AND DEVELOPMENT. 2006 FEB; 127 (2): 188-202	22	29	80	110
184	19232 Tolnay M, Frank S Pathology and genetics of frontotemporal lobar degeneration: an update CLINICAL NEUROPATHOLOGY. 2007 JUL-AUG; 26 (4): 143-156	2	2	80	134
185	19907 Lacor PN Advances on the understanding of the origins of synaptic pathology in AD CURRENT GENOMICS. 2007 DEC; 8 (8): 486-508	2	5	80	358
186	22403 Denk F, Wade-Martins R Knock-out and transgenic mouse models of tauopathies NEUROBIOLOGY OF AGING. 2009 JAN; 30 (1): 1-13	9	12	80	95
187	22733 Spires-Jones TL, Stoothoff WH, de Calignon A, Jones PB, Hyman BT Tau pathophysiology in neurodegeneration: a tangled issue TRENDS IN NEUROSCIENCES. 2009 MAR; 32 (3): 150-159	28	40	80	114
188	23223 Malkus KA, Tsika E, Ischiropoulos H Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle MOLECULAR NEURODEGENERATION. 2009 JUN 5; 4: Art. No. 24	2	8	80	240
189	23518 Jung T, Catalgol B, Grune T The proteasomal system MOLECULAR ASPECTS OF MEDICINE. 2009 AUG; 30 (4): 191-296	1	31	80	1413
190	24262 Sieegers K, Cruts M, Van Broeckhoven C Molecular Pathways of Frontotemporal Lobar Degeneration ANNUAL REVIEW OF NEUROSCIENCE, VOL 33. 2010; 33: 71-88	0	0	80	127
#	Date / Author / Journal	LCS	GCS	LCR	CR
191	24312 Gong CX, Grundke-Iqbal I, Iqbal K Targeting Tau Protein in Alzheimer's Disease DRUGS & AGING. 2010; 27 (5): 351-365	0	1	80	154
192	24809 Pickering-Brown SM Review: Recent progress in frontotemporal lobar degeneration NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 FEB; 36 (1): 4-16	0	1	80	117
193	25189 De Strooper B Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process PHYSIOLOGICAL REVIEWS. 2010 APR; 90 (2): 465-494	1	12	80	367
194	25412 Jellinger KA, Lantos PL Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update ACTA NEUROPATHOLOGICA. 2010 JUN; 119 (6): 657-667	2	2	80	125
195	26547 Vandrovcova J, Anaya F, Kay V, Lees A, Hardy J, et al. Disentangling the Role of the Tau Gene Locus in Sporadic Tauopathies CURRENT ALZHEIMER RESEARCH. 2010 DEC; 7 (8): 726-734	1	1	80	116
196	20595 Cozzolino M, Ferri A, Carri MT Amyotrophic lateral sclerosis: From current developments in the laboratory to clinical implications ANTIOXIDANTS & REDOX SIGNALING. 2008 MAR; 10 (3): 405-443	8	39	79	439
197	22096 Buratti E, Baralle FE The Molecular Links Between TDP-43 Dysfunction and Neurodegeneration ADVANCES IN GENETICS, VOL 66. 2009; 66: 1-34	11	12	79	111
198	9726 Brandt R Cytoskeletal mechanisms of neuronal degeneration CELL AND TISSUE RESEARCH. 2001 AUG; 305 (2): 255-265	14	30	78	111
199	22668 Savage MJ, Gingrich DE Advances in the Development of Kinase Inhibitor Therapeutics for Alzheimer's Disease DRUG DEVELOPMENT RESEARCH. 2009 MAR; 70 (2): 125-144	2	5	78	221
200	24924 Iijima-Ando K, Iijima K Transgenic Drosophila models of Alzheimer's disease and tauopathies BRAIN STRUCTURE & FUNCTION. 2010 MAR; 214 (2-3): 245-262	0	1	78	185

Date / Author / Journal

LCS

GCS

LCR

101

14523 Cairns NJ, Lee VMY, Trojanowski JQ

The cytoskeleton in neurodegenerative diseases

JOURNAL OF PATHOLOGY. 2004 NOV; 204 (4): 438-449

125

102

26945 Archer T, Kostrzewa RM, Beninger RJ, Palomo T

Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions

NEUROTOXICITY RESEARCH. 2011 FEB; 19 (2): 211-234

339

103

16496 Gong CX, Liu F, Grundke-Iqbal I, Iqbal K

Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: A therapeutic target

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 31825

159

104

13682 Sidhu A, Wersinger C, Vernier P

Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?

FASEB JOURNAL. 2004 APR; 18 (6): 637-647

145

105

14383 von Bohlen und Halbach O

Synucleins and their relationship to Parkinson's disease

CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 163-174

143

106

19784 Ahmad M, Attoub S, Singh MN, Martin FL, El-Agnaf OMA

gamma-synuclein and the progression of cancer

FASEB JOURNAL. 2007 NOV; 21 (13): 3419-3430

144

107

23099 Olanow CW, Stern MB, Sethi K

The scientific and clinical basis for the treatment of Parkinson disease (2009)

NEUROLOGY. 2009 MAY 26; 72 (21): S1-S136

1050

108

26336 Yasuda T, Mochizuki H

The regulatory role of alpha-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease

APOPTOSIS. 2010 NOV; 15 (11): 1312-1321

159

109

10900 Avila J, Lim F, Moreno F, Belmonte C, Cuello AC

Tau function and dysfunction in neurons - Its role in neurodegenerative disorders

MOLECULAR NEUROBIOLOGY. 2002 JUN; 25 (3): 213-231

185

110

22662 George JL, Mok S, Moses D, Wilkins S, Bush AI, et al.

Targeting the Progression of Parkinson's Disease

CURRENT NEUROPHARMACOLOGY. 2009 MAR; 7 (1): 9-36

454

Date / Author / Journal

LCS

GCS

LCR

111

23522 Craig-Schapiro R, Fagan AM, Holtzman DM

Biomarkers of Alzheimer's disease

NEUROBIOLOGY OF DISEASE. 2009 AUG; 35 (2): 128-140

298

112

17947 Olanow CW, McNaught KS

Ubiquitin-proteasome system and Parkinson's disease

MOVEMENT DISORDERS. 2006 NOV; 21 (11): 1806-1823

231

113

16999 McNaught KSP, Olanow CW

Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease

NEUROBIOLOGY OF AGING. 2006 APR; 27 (4): 530-545

256

114

20318 Halliday GM, McCann H

Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms

EXPERIMENTAL NEUROLOGY. 2008 JAN; 209 (1): 12-21

139

115

22805 Levy OA, Malagelada C, Greene LA

Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps

APOPTOSIS. 2009 APR; 14 (4): 478-500

239

116

12317 Lee SJ

alpha-synuclein aggregation: A link between mitochondrial defects and Parkinson's disease?

ANTIOXIDANTS & REDOX SIGNALING. 2003 JUN; 5 (3): 337-348

138

117

17550 Beyer K

alpha-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers

ACTA NEUROPATHOLOGICA. 2006 SEP; 112 (3): 237-251

136

118

25453 Bento-Abreu A, Van Damme P, Van Den Bosch L, Robberecht W

The neurobiology of amyotrophic lateral sclerosis

EUROPEAN JOURNAL OF NEUROSCIENCE. 2010 JUN; 31 (12): 2247-2265

275

119

9704 Sanchez MP, Alvarez-Tallada V, Avila J

The microtubule associated protein tau in neurodegenerative diseases. Tauopathies

REVISTA DE NEUROLOGIA. 2001 JUL 16; 33 (2): 169-177

176

120

19888 Fiala JC

Mechanisms of amyloid plaque pathogenesis

ACTA NEUROPATHOLOGICA. 2007 DEC; 114 (6): 551-571

300

Date / Author / Journal

LCS

GCS

LCR

121

22524 Bisaglia M, Mammi S, Bubacco L

Structural insights on physiological functions and pathological effects of alpha-synuclein

FASEB JOURNAL. 2009 FEB; 23 (2): 329-340

126

122

7684 Heininger K

A unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 1999 DEC; 14 (8): 525-581

796

123

9078 Arendt T

Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization

NEUROSCIENCE. 2001; 102 (4): 723-765

836

124

14150 Huang Y, Cheung L, Rowe D, Halliday G

Genetic contributions to Parkinson's disease

BRAIN RESEARCH REVIEWS. 2004 AUG; 46 (1): 44-70

300

125

19700 Wakabayashi K, Tanji K, Mori F, Takahashi H

The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of alpha-synuclein aggregates

NEUROPATHOLOGY. 2007 OCT; 27 (5): 494-506

150

126

7217 Goedert M

Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B- BIOLOGICAL SCIENCES. 1999 JUN 29; 354 (1386): 1101-1118

148

127

14915 Thompson HJ, Lifshitz J, Marklund N, Grady MS, Graham DI, et al.

Lateral fluid percussion brain injury: A 15-year review and evaluation

JOURNAL OF NEUROTRAUMA. 2005 JAN; 22 (1): 42-75

105

375

128

20334 Iqbal K, Grundke-Iqbal I

Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2008 JAN-FEB; 12 (1): 38-55

166

129

23668 Bauer PO, Nukina N

The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies

JOURNAL OF NEUROCHEMISTRY. 2009 SEP; 110 (6): 1737-1765

360

130

25392 Bartolini M, Andrisano V

Strategies for the Inhibition of Protein Aggregation in Human Diseases

CHEMBIOCHEM. 2010 MAY 17; 11 (8): 1018-1035

302

Date / Author / Journal

131

General aspects of neurodegeneration

ADVANCES IN RESEARCH ON NEURODEGENERATION. 2003; 10: 101-144

198

132

11735 Jellinger KA

General aspects of neurodegeneration

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2003; (65): 101-144

198

133

14968 Stoothoff WH, Johnson GVW

Tau phosphorylation: physiological and pathological consequences

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 280-297

102

170

134

15782 Goedert M

Tau gene mutations and their effects

MOVEMENT DISORDERS. 2005 AUG; 20: S45-S52

135

20266 Duyckaerts C, Potier MC, Delatour B

Alzheimer disease models and human neuropathology: similarities and differences

ACTA NEUROPATHOLOGICA. 2008 JAN; 115 (1): 5-38

350

136

25546 Dawson TM, Ko HS, Dawson VL

Genetic Animal Models of Parkinson's Disease

NEURON. 2010 JUN 10; 66 (5): 646-661

161

137

26895 Uversky VN

Flexible Nets of Malleable Guardians: Intrinsically Disordered Chaperones in Neurodegenerative Diseases

CHEMICAL REVIEWS. 2011 FEB; 111 (2): 1134-1166

459

138

13196 Snyder H, Wolozin B

Pathological proteins in Parkinson's disease

JOURNAL OF MOLECULAR NEUROSCIENCE. 2004; 24 (3): 425-442

179

139

16591 Niewiadomska G, Baksalerska-Pazera M, Riedel G

Cytoskeletal transport in the aging brain: Focus on the cholinergic system

REVIEWS IN THE NEUROSCIENCES. 2006; 17 (6): 581-618

329

140

17139 Lashuel HA, Lansbury PT

Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?

QUARTERLY REVIEWS OF BIOPHYSICS. 2006 MAY; 39 (2): 167-201

101

307

Date / Author / Journal

LCS

GCS

LCR

141

24968 Meraz-Rios MA, Lira-De Leon KI, Campos-Pena V, De Anda-Hernandez MA, Mena-Lopez R

Tau oligomers and aggregation in Alzheimer's disease

JOURNAL OF NEUROCHEMISTRY. 2010 MAR; 112 (6): 1353-1367

140

142

7472 Buee L, Delacourte A

Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease

BRAIN PATHOLOGY. 1999 OCT; 9 (4): 681-693

123

147

131

143

11765 Yancopoulou D, Spillantini MG

Tau protein in familial and sporadic diseases

NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 37-48

101

144

14953 D'Souza I, Schellenberg GD

Regulation of tau isoform expression and dementia

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 104-115

117

145

22373 Biran Y, Masters CL, Barnham KJ, Bush AI, Adlard PA

Pharmacotherapeutic targets in Alzheimer's disease

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2009 JAN; 13 (1): 61-86

427

146

23478 Madine J, Middleton DA

TARGETING alpha-SYNUCLEIN AGGREGATION FOR PARKINSON'S DISEASE TREATMENT

DRUGS OF THE FUTURE. 2009 AUG; 34 (8): 655-663

134

147

23858 Crews L, Tsigelny I, Hashimoto M, Masliah E

Role of Synucleins in Alzheimer's Disease

NEUROTOXICITY RESEARCH. 2009 OCT; 16 (3): 306-317

151

148

25800 Robinson PA

Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy

EXPERT REVIEW OF PROTEOMICS. 2010 AUG; 7 (4): 565-578

208

149

9568 Goedert M

The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases

CURRENT OPINION IN GENETICS & DEVELOPMENT. 2001 JUN; 11 (3): 343-351

150

11590 Ingram EM, Spillantini MG

Tau gene mutations: dissecting the pathogenesis of FTDP-17

TRENDS IN MOLECULAR MEDICINE. 2002 DEC; 8 (12): 555-562

Date / Author / Journal

LCS

GCS

LCR

151

15389 Norris EH, Giasson BI

Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders

ANTIOXIDANTS & REDOX SIGNALING. 2005 MAY-JUN; 7 (5-6): 673-684

136

152

22120 Gotz J, Gotz NN

Animal models for Alzheimer's disease and frontotemporal dementia: a perspective

ASN NEURO. 2009; 1 (4): Art. No. e00019

134

153

22676 Beyer K, Domingo-Sabat M, Ariza A

Molecular Pathology of Lewy Body Diseases

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 724-745

145

154

23505 Geser F, Martinez-Lage M, Kwong LK, Lee VMY, Trojanowski JQ

Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases

JOURNAL OF NEUROLOGY. 2009 AUG; 256 (8): 1205-1214

108

155

24790 Grossman M

Primary progressive aphasia: clinicopathological correlations

NATURE REVIEWS NEUROLOGY. 2010 FEB; 6 (2): 88-97

129

156

21728 Ninkina NN, Ustyugov AA, Buchman VL

Modeling Synucleinopathies in Genetically Modified Animals: Successes and Failures

MOLECULAR BIOLOGY. 2008 OCT; 42 (5): 747-761

102

157

26572 Bekris LM, Mata IF, Zabetian CP

The Genetics of Parkinson Disease

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2010 DEC; 23 (4): 228-242

215

158

13689 Bertoli-Avella AM, Oostra BA, Heutink P

Chasing genes in Alzheimer's and Parkinson's disease

HUMAN GENETICS. 2004 APR; 114 (5): 413-438

305

159

18225 Jellinger KA

Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2007; (72): 91-104

168

160

23275 Lim KL, Ng CH

Genetic models of Parkinson disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 604-615

156

Date / Author / Journal

161

A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events

REVIEWS IN THE NEUROSCIENCES. 2000; 11: 213-328

1849

162

14062 Gotz J, Streffer JR, David D, Schild A, Hoerndli F, et al.

Transgenic animal models of Alzheimer's disease and related disorders: Histopathology, behavior and therapy

MOLECULAR PSYCHIATRY. 2004 JUL; 9 (7): 664-683

101

206

163

20202 Dohm CP, Kermer P, Bahr M

Aggregopathy in neurodegenerative diseases: Mechanisms and therapeutic implication

NEURODEGENERATIVE DISEASES. 2008; 5 (6): 321-338

206

164

21429 Jellinger KA, Janetzky B, Attems J, Kienzl E

Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene' - a new blood biomarker ?

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2008 AUG; 12 (4): 1094-1117

302

165

21723 van Swieten JC, Heutink P

Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia

LANCET NEUROLOGY. 2008 OCT; 7 (10): 965-974

104

166

23838 Brunden KR, Trojanowski JQ, Lee VMY

Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

NATURE REVIEWS DRUG DISCOVERY. 2009 OCT; 8 (10): 783-793

137

167

6223 Anderton BH, Callahan L, Coleman P, Davies P, Flood D, et al.

Dendritic changes in Alzheimer's disease and factors that may underlie these changes

PROGRESS IN NEUROBIOLOGY. 1998 AUG; 55 (6): 595-609

191

168

15663 Kuret J, Congdon EE, Li GB, Yin HH, Yu X, et al.

Evaluating triggers and enhancers of tau fibrillization

MICROSCOPY RESEARCH AND TECHNIQUE. 2005 JUL; 67 (3-4): 141-155

160

169

15972 Kar A, Kuo D, He RQ, Zhou JW, Wu JY

Tau alternative splicing and frontotemporal dementia

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19: S29-S36

170

19085 Inamdar NN, Arulmozhi DK, Tandon A, Bodhankar SL

Parkinson's disease: Genetics and beyond

CURRENT NEUROPHARMACOLOGY. 2007 JUN; 5 (2): 99-113

291

Date / Author / Journal

LCS

GCS

LCR

171

20790 Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, et al.

Biochemistry of Tau in Alzheimer's disease and related neurological disorders

EXPERT REVIEW OF PROTEOMICS. 2008 APR; 5 (2): 207-224

161

172

25171 Chen-Plotkin AS, Lee VMY, Trojanowski JQ

TAR DNA-binding protein 43 in neurodegenerative disease

NATURE REVIEWS NEUROLOGY. 2010 APR; 6 (4): 211-220

121

173

26154 Wisniewski T, Sigurdsson EM

Murine models of Alzheimer's disease and their use in developing immunotherapies

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 847-859

236

174

8383 Sanchez C, Diaz-Nido J, Avila J

Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function

PROGRESS IN NEUROBIOLOGY. 2000 JUN; 61 (2): 133-168

176

473

175

11094 Kahle PJ, Haass C, Kretzschmar HA, Neumann M

Structure/function of alpha-synuclein in health and disease: rational development of animal models for Parkinson's and related diseases

JOURNAL OF NEUROCHEMISTRY. 2002 AUG; 82 (3): 449-457

100

176

14960 Iqbal K, Alonso ADC, Chen S, Chohan MO, El-Akkad E, et al.

Tau pathology in Alzheimer disease and other tauopathies

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 198-210

100

154

147

177

18166 Furumoto S, Okamura N, Iwata R, Yanai K, Arai H, et al.

Recent advances in the development of amyloid Imaging agents

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2007; 7 (18): 1773-1789

167

178

20559 Wright JA, Brown DR

Alpha-synuclein and its role in metal binding: Relevance to Parkinson's disease

JOURNAL OF NEUROSCIENCE RESEARCH. 2008 FEB 15; 86 (3): 496-503

103

179

23440 Mollenhauer B, Trenkwalder C

Neurochemical Biomarkers in the Differential Diagnosis of Movement Disorders

MOVEMENT DISORDERS. 2009 JUL 30; 24 (10): 1411-1426

299

180

25177 Geser F, Lee VMY, Trojanowski JQ

Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: A spectrum of TDP-43 proteinopathies

NEUROPATHOLOGY. 2010 APR; 30 (2): 103-112

104

Date / Author / Journal

LCS

GCS

LCR

181

25734 Schulz-Schaeffer WJ

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia

ACTA NEUROPATHOLOGICA. 2010 AUG; 120 (2): 131-143

157

182

10323 Cole NB, Murphy DD

The cell biology of alpha-synuclein - A sticky problem?

NEUROMOLECULAR MEDICINE. 2002; 1 (2): 95-109

128

183

16751 Mukaetova-Ladinska EB, McKeith IG

Pathophysiology of synuclein aggregation in Lewy body disease

MECHANISMS OF AGEING AND DEVELOPMENT. 2006 FEB; 127 (2): 188-202

110

184

19232 Tolnay M, Frank S

Pathology and genetics of frontotemporal lobar degeneration: an update

CLINICAL NEUROPATHOLOGY. 2007 JUL-AUG; 26 (4): 143-156

134

185

19907 Lacor PN

Advances on the understanding of the origins of synaptic pathology in AD

CURRENT GENOMICS. 2007 DEC; 8 (8): 486-508

358

186

22403 Denk F, Wade-Martins R

Knock-out and transgenic mouse models of tauopathies

NEUROBIOLOGY OF AGING. 2009 JAN; 30 (1): 1-13

187

22733 Spires-Jones TL, Stoothoff WH, de Calignon A, Jones PB, Hyman BT

Tau pathophysiology in neurodegeneration: a tangled issue

TRENDS IN NEUROSCIENCES. 2009 MAR; 32 (3): 150-159

114

188

23223 Malkus KA, Tsika E, Ischiropoulos H

Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle

MOLECULAR NEURODEGENERATION. 2009 JUN 5; 4: Art. No. 24

240

189

23518 Jung T, Catalgol B, Grune T

The proteasomal system

MOLECULAR ASPECTS OF MEDICINE. 2009 AUG; 30 (4): 191-296

1413

190

24262 Sieegers K, Cruts M, Van Broeckhoven C

Molecular Pathways of Frontotemporal Lobar Degeneration

ANNUAL REVIEW OF NEUROSCIENCE, VOL 33. 2010; 33: 71-88

127

Date / Author / Journal

LCS

GCS

LCR

191

24312 Gong CX, Grundke-Iqbal I, Iqbal K

Targeting Tau Protein in Alzheimer's Disease

DRUGS & AGING. 2010; 27 (5): 351-365

154

192

24809 Pickering-Brown SM

Review: Recent progress in frontotemporal lobar degeneration

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 FEB; 36 (1): 4-16

117

193

25189 De Strooper B

Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process

PHYSIOLOGICAL REVIEWS. 2010 APR; 90 (2): 465-494

367

194

25412 Jellinger KA, Lantos PL

Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update

ACTA NEUROPATHOLOGICA. 2010 JUN; 119 (6): 657-667

125

195

26547 Vandrovcova J, Anaya F, Kay V, Lees A, Hardy J, et al.

Disentangling the Role of the Tau Gene Locus in Sporadic Tauopathies

CURRENT ALZHEIMER RESEARCH. 2010 DEC; 7 (8): 726-734

116

196

20595 Cozzolino M, Ferri A, Carri MT

Amyotrophic lateral sclerosis: From current developments in the laboratory to clinical implications

ANTIOXIDANTS & REDOX SIGNALING. 2008 MAR; 10 (3): 405-443

439

197

22096 Buratti E, Baralle FE

The Molecular Links Between TDP-43 Dysfunction and Neurodegeneration

ADVANCES IN GENETICS, VOL 66. 2009; 66: 1-34

111

198

9726 Brandt R

Cytoskeletal mechanisms of neuronal degeneration

CELL AND TISSUE RESEARCH. 2001 AUG; 305 (2): 255-265

111

199

22668 Savage MJ, Gingrich DE

Advances in the Development of Kinase Inhibitor Therapeutics for Alzheimer's Disease

DRUG DEVELOPMENT RESEARCH. 2009 MAR; 70 (2): 125-144

221

200

24924 Iijima-Ando K, Iijima K

Transgenic Drosophila models of Alzheimer's disease and tauopathies

BRAIN STRUCTURE & FUNCTION. 2010 MAR; 214 (2-3): 245-262

185

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records